Advertisement

Topics

AsiaPacific In Vitro Diagnostics Market Opportunities and Forecasts, 2015 2022 [Report Updated: 01022016] Prices from USD $3390

04:32 EDT 11 Aug 2017 | BioPortfolio Reports

In vitro diagnostics IVD is a method used for detection and identification of diseases in an artificial environment using samples such as blood, urine, stool, tissues and other body fluids, which are derived from the human body. IVD includes several techniques such as immunodiagnostic, infectious diseases testing, blood testing, clinical chemistry, molecular diagnosis and other such techniques. Considerable increase in the number of chronic and infectious diseases, growing awareness towards healthcare solutions and technological advancements in healthcare industry encouraged doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines.nnThe overall revenue of the Asia Pacific IVD market accounted for about $12.9 billion in 2015, and is estimated to reach $19.0 billion by 2022, registering a CAGR of 5.6% over the forecast period. The increased application of personalized medicines and widespread knowledge of rare diseases are boosting the growth of Asia Pacific IVD market. Moreover, growing need of IVD testing owing to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders drives the market growth. The Asia Pacific IVD market has evolved over the years with the launch of several innovative techniques used across multiple therapeutic areas. However, stringent regulatory policies and reimbursements issues in few countries limit the growth of this market. The rising demand for technologically advanced diagnostic devices, rise in GDP and per capita income and rise in disposable incomes facilitate a huge potential for the Asia Pacific IVD market in the AsiaPacific region. Similarly, the development of a new range of conditionspecific markers and tests along with the advancement in genomics and proteomics are creating new opportunities in emerging economies.nnThe AsiaPacific IVD market is segmented based on product type, technique, indications, end user and country. Based on technique, the market is segmented into immunodiagnostics, blood testing, molecular diagnostics, tissue diagnostics, clinical chemistry and other clinical technique. Immunodiagnostic is the highest revenuegenerating segment in the overall IVD techniques market. However, the blood testing is the fastest growing technique in the overall IVD techniques market due to its ability to accurately detect the primary cause of the disease.nnBased on product type, the market is segmented into instruments, reagents, services amp; software. Reagents held the highest market share in the Asia Pacific IVD market followed by rapidly growing instrument segment. Reagents are largely used in various equipment and play a key role in the overall diagnosis process. The application segment is categorized into infectious diseases, cancer, cardiac diseases, immune system diseases, nephrological diseases, gastrointestinal diseases, and others. Infectious diseases segment was the highest revenuegenerating segment in 2015 and would continue to maintain its position throughout the forecast period, due to the rise in incidences of infectious diseases such as HIV/AIDS, Chlamydia and Hepatitis.nnHospitals and laboratories, academics amp; medical schools, pointofcare testing and others form the end users segment in the AsiaPacific IVD market. Standalone laboratories generate the highest revenue, followed by hospitals. A significant rise in the number of hospitals and laboratories across the AsiaPacific region along with increased awareness about developments in healthcare largely contribute to the growth of these segment.nBased on country, the AsiaPacific IVD market is segmented into India, China, Japan, Australia, and other AsiaPacific countries. Japan held the dominant share, around 35.3% in 2015 in the AsiaPacific IVD market, owing to the high demand for testing in outpatient clinics, huge population base and rising medical insurance services by the Japan government. Moreover, China and Australia hold the significant market share due to the wellsupported reimbursement facilities and wellregulated IVD devices, which comes under the regulation of medical devices. However, India registers highest CAGR i.e. 7.1% during the forecast period.nnProduct launch was the key strategy adopted by market payers, owing to the dynamic nature of the market in terms of technology advancement. The leading companies profiled in this report are, Danaher Corporation, Vela Diagnostics, Siemens AG, Affymetrix, Alere Inc., BioMerieux, Roche Diagnostics, BioRad Laboratories, Becton, Dickinson And Company, Abbott Laboratories Inc., Arkray Inc., Sysmex Corporation, Johnson amp; Johnson, Siemens Healthcare and Trans Asia BioMedicals Ltd.nnKEY BENEFITS FOR STAKEHOLDERS:nnnnThis report entails the detailed quantitative analysis of the current market and estimations from 2015 to 2022, which assists in identifying the prevailing market opportunitiesnnExhaustive analysis of the Asia Pacific IVD market by product type helps in understanding the types of instruments and reagents that are currently being used during disease diagnostic that would gain prominence in the futurennCountrywise Asia Pacific IVD market conditions are comprehensively analyzed in this report. Increasing awareness about chronic diseases in developing economies is expected to drive the growth of the marketnnExtensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the market frameworknnKey market players within the Asia Pacific IVD market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of Asia Pacific IVD marketnnnAPAC IVD MARKET KEY SEGMENTS:nnnnnnBy Product typennnnnnReagentsnnnInstrumentsnnnSoftware amp; ServicesnnnnnnBy TechniquesnnnnnImmunodiagnosticsnnnBlood TestingnnnMolecular DiagnosticsnnnTissue DiagnosticsnnnClinical ChemistrynnnOther IVD TechniquesnnnnnnBy ApplicationnnnnnInfectious DiseasesnnnCancernnnCardiac DiseasesnnnImmune System DisordersnnnNephrological DiseasesnnnGastrointestinal DiseasesnnnOther IndicationsnnnnnnBy End UsersnnnnnStandalone LaboratorynnnHospitalsnnnAcademic amp; Medical SchoolsnnnPoint of CarennnOthersnnnnnnBy CountrynnnnnIndiannnChinannnJapannnnAustraliannnOthersnnnnn

Original Article: AsiaPacific In Vitro Diagnostics Market Opportunities and Forecasts, 2015 2022 [Report Updated: 01022016] Prices from USD $3390

NEXT ARTICLE

More From BioPortfolio on "AsiaPacific In Vitro Diagnostics Market Opportunities and Forecasts, 2015 2022 [Report Updated: 01022016] Prices from USD $3390"

Quick Search
Advertisement
 

Relevant Topic

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...